Journal profile · Genetics & Heredity
HEREDITAS
ISSN 0018-0661 · eISSN 1601-5223 · BioMed Central · DENMARK · Bimonthly · Founded 2015
HEREDITAS: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 2.46; fully open access; APC about USD 2,690; median 115 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 259 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
HEREDITAS is published by BioMed Central and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chromosomal and Genetic Variations, Botanical Research and Chemistry and Plant Reproductive Biology, together about 30.8% of its articles. Its main subfields are Plant Science and Ecology, Evolution, Behavior and Systematics. (generated from OpenAlex topic counts and CAS ranking data)
Hereditas is an open access, peer-reviewed journal, and the official publication of the Mendelian Society of Lund, dedicated to advancing genetics and genomics research across human and animal. Building on a century-long legacy in genetics, the journal publishes high-quality research spanning fundamental discoveries, evolutionary insights, and applied studies that impact medicine and biotechnology. We welcome submissions that shed light on inheritance, genetic diversity, molecular mechanisms, and application of genome-scale technologies. Areas of Interest 1. Medical and clinical genetics Studies of genetic and epigenetic alterations underlying human disease, including cancer genetics, hereditary syndromes, pharmacogenomics, and diagnostic or prognostic applications of genomics. This area emphasizes clinically relevant discoveries that advance diagnosis, risk stratification, and patient management. 2. Regulatory genomics and non-coding RNAs Investigations into non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, as well as other regulatory elements that govern gene expression in health, and human diseases. These studies advance understanding of complex regulatory networks at the genomic level. 3. Genomic technologies and data science Research employing high-throughput sequencing, genome-wide association studies, functional and population genomics, integrative multi-omics, and bioinformatics approaches to explore genetic diversity in human diseases. Computational predictions and models need to be confirmed with experimental validation performed in vitro or in vivo to ensure biological relevance. 4. Gene therapy and genomic medicine Studies on gene-based therapeutic interventions, including CRISPR technologies, RNA-based therapies, delivery systems, and clinical applications of gene editing. This theme reflects the transition from genetic diagnosis to treatment of human diseases for personalized medicine. 5. Plant genetics and genomics Studies on genetic and epigenetic mechanisms underlying plant development, adaptation, and evolution, including molecular and classical genetics, cytogenetics, population genomics, and genome organization in wild and cultivated species. This scope includes research on plant domestication, breeding, stress responses, and genetic diversity, with relevance to agriculture, biodiversity, and environmental change.
From the journal's Aims & Scope
Research area (LetPub): Genetics & Heredity
Editor-in-chief Ramin MassoumiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chromosomal and Genetic VariationsAgricultural and Biological Sciences12.4%
- Botanical Research and ChemistryAgricultural and Biological Sciences11.6%
- Plant Reproductive BiologyBiochemistry, Genetics and Molecular Biology6.8%
- Wheat and Barley Genetics and PathologyAgricultural and Biological Sciences6.4%
- Genetic diversity and population structureBiochemistry, Genetics and Molecular Biology6.4%
- Plant and animal studiesAgricultural and Biological Sciences6%
- Genetic Mapping and Diversity in Plants and AnimalsBiochemistry, Genetics and Molecular Biology4.6%
- Plant Taxonomy and PhylogeneticsAgricultural and Biological Sciences4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.46LetPub ·
- Impact factor (publisher) 2025
- 2.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 45LetPub ·
- h-index
- 112OpenAlex ·
- i10-index
- 3,039OpenAlex ·
- 2-year mean citedness
- 2.01OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 251LetPub ·
- Downloads per year (publisher) 2025
- 536,500Publisher website ·
Articles by year OpenAlex count · 6,311 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 112 | 112 | 46 |
| 2025 | 259 | 259 | 569 |
| 2024 | 57 | 57 | 244 |
| 2023 | 39 | 39 | 339 |
| 2022 | 47 | 47 | 503 |
| 2021 | 48 | 48 | 674 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 79 days – 156 days
- Acceptance to online
- median 14 days (102 articles)
- Submission to online
- median 140 days
- Sample
- 102 articles with submission and acceptance dates (369 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,290 / USD 2,690 / GBP 1,990 | Yes | CC BY, CC0 | |
| OpenAlex | USD 2,590 / EUR 2,190 / GBP 1,890 | — | — | |
| LetPub | GBP 1,790 / USD 2,490 / EUR 2,090 | Yes | — | |
| Publisher website | GBP 1,990 / USD 2,690 / EUR 229 / EUR 2,290 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- brief reportResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- commentaryResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- letter to the editorResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- meeting reportResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- opinionResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- researchResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- reviewResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
- softwareResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting ReportLength not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review
- Authorship
Manuscripts may only be submitted by an author, not a third party Model summary
Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Source ↗Publisher website ·- Data availability Formatting the 'Availability of data and materials' section of your manuscript
CC0 1.0 Public Domain Dedication waiver applies to all published data Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons Attribution 4.0 International (CC BY) licence for articles Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Hereditas articles are published open access under a CC BY (Creative Commons Attribution 4.0 International l…
Source ↗Publisher website ·- Open access Benefits of open access
APC waivers/discounts for corresponding authors in the world's lowest income countries Model summary
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Authors may suggest peer reviewers with institutional email addresses or identifiers (ORCID/Scopus ID) Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- DENMARK
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2015
- ISSN
- 0018-0661
- Electronic ISSN
- 1601-5223
- Society / sponsor
- Mendelian Society of Lund
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about HEREDITAS
What CAS zone is HEREDITAS in?
In the 2025 upgraded edition of the CAS Journal Ranking, HEREDITAS is in Zone 4 of Biology, and in Zone 4 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of HEREDITAS?
The latest impact factor listed by LetPub is 2.46; CiteScore 2.3, h-index 112.
How long does peer review take at HEREDITAS?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 79–156 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index HEREDITAS?
According to LetPub and DOAJ records, HEREDITAS is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is HEREDITAS open access, and what is the APC?
HEREDITAS is a fully open-access journal. APC about USD 2,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .